2022
DOI: 10.14309/01.ajg.0000857664.27592.13
|View full text |Cite
|
Sign up to set email alerts
|

S256 Risk Factors of Colorectal Cancer in Africa: A Systematic Review and Meta-Analysis

Abstract: Introduction:The United States Preventive Services Taskforce lowered the recommended starting age for colorectal cancer (CRC) screening in average-risk adults from 50 to 45 years due to a rapid increase in young CRC incidence and overall favorable benefit-to-burden ratio in the US. This recommendation has not been widely adopted by other countries partially because the burden of young CRC in these countries is unclear compared to the United States.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The successful transfer of the program from FCD to Addis Ababa University CDT-Africa facilitated country ownership and positioned the local partner institution as a sustainable LMIC training hub. Previous studies on training initiatives for health professionals in Africa have shown the potential to improve competency and performance[30][31][32][33][34], yet there is limited information on competency in clinical trial capacity. The program's success in enhancing participants' pro ciency in clinical trials was notably marked by a signi cant improvement.…”
mentioning
confidence: 99%
“…The successful transfer of the program from FCD to Addis Ababa University CDT-Africa facilitated country ownership and positioned the local partner institution as a sustainable LMIC training hub. Previous studies on training initiatives for health professionals in Africa have shown the potential to improve competency and performance[30][31][32][33][34], yet there is limited information on competency in clinical trial capacity. The program's success in enhancing participants' pro ciency in clinical trials was notably marked by a signi cant improvement.…”
mentioning
confidence: 99%